Competition & Markets Authority
Medical device suppliers’ merger raises competition concerns
The CMA has concluded that the merger of 2 suppliers of medical devices could lead to a reduction of competition in the supply of total ankle replacement prosthetics.
The Competition and Markets Authority (CMA) is concerned that, should the proposed £4.2 billion purchase by Stryker Corporation (Stryker) of Wright Medical Group N.V. (Wright) go ahead, it would have a negative impact on vulnerable patients in the UK who need ankle replacements.
Stryker and Wright both manufacture a range of orthopaedic products for patients requiring assistance with their feet, ankles and hands. The total ankle replacement prosthetics produced by Stryker and Wright are predominantly used in elderly orthopaedic patients suffering from arthritis.
Following its initial Phase 1 investigation, the CMA found that the proposed merger would result in the merged entity having a share of over 90% in the total ankle replacement prostheses market in the UK. Should the deal go ahead as planned, the CMA is concerned that Stryker would not face enough competition from other suppliers, leading to higher prices or less choice for hospitals and their patients.
Joel Bamford, CMA Senior Director, yesterday said:
The CMA is concerned that this merger and the resulting reduction in competition could lead to worse outcomes for hospitals and patients. The companies are the two major producers of vital medical products for vulnerable people suffering from serious degenerative conditions such as arthritis.
Healthy competition in the medical technology market is central to continued innovation and improvements in patient treatments.
Stryker and Wright now have until 7 July 2020 to address the CMA’s concerns through the offer of undertakings in lieu of a Phase 2 reference. If they are unable to address the CMA’s concerns, the deal will be referred for an in-depth Phase 2 investigation.
For more information, visit the Stryker/Wright Medical merger inquiry web page.
For media enquiries, contact the CMA press office on 020 3738 6460 or email@example.com.
Latest News from
Competition & Markets Authority
CMA final decision on air traffic control charges24/07/2020 09:20:00
The CMA has sent the CAA its final price control determination on a dispute between the aviation regulator and NERL regarding air traffic control charges.
Roland fined £4 million for illegally preventing online price discounts23/07/2020 13:38:00
Lessons from the CMA’s investigation into Roland's use of illegal resale price maintenance (RPM).
How should competition policy react to coronavirus?22/07/2020 12:20:00
IPPR yesterday published a paper by CMA Chairman Andrew Tyrie, discussing how competition policy can contribute to a robust and sustainable post-crisis recovery.
Customers could lose out in merger between window blind companies17/07/2020 09:20:00
The CMA has provisionally found that Hunter Douglas’ purchase of 247 Home Furnishings Ltd raises competition concerns.
CMA publishes Annual Report 2019/202015/07/2020 13:48:00
The CMA has published its Annual Report, highlighting the wide range of work the UK competition and consumer authority has carried out in the past year.
CMA levies fines of £2.3m and secures £8m for NHS in pharma probe10/07/2020 09:20:00
The CMA has formally concluded that 3 pharmaceutical companies took part in an illegal arrangement in relation to the supply of life-saving medicine.
Korg fined £1.5 million for illegally preventing online price discounts09/07/2020 14:20:00
Lessons from the CMA’s investigation into Korg's use of illegal resale price maintenance (RPM).
CMA orders insurance provider to fix PPI breaches08/07/2020 15:10:00
The CMA has taken action against Cardif Pinnacle, and written to Nationwide and Lloyds, after they failed to provide accurate annual PPI reminders.